Literature DB >> 3125548

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

D L DeWitt1, W L Smith.   

Abstract

Prostaglandin G/H synthase (8,11,14-icosatrienoate, hydrogen-donor:oxygen oxidoreductase, EC 1.14.99.1) catalyzes the first step in the formation of prostaglandins and thromboxanes, the conversion of arachidonic acid to prostaglandin endoperoxides G and H. This enzyme is the site of action of nonsteroidal anti-inflammatory drugs. We have isolated a 2.7-kilobase complementary DNA (cDNA) encompassing the entire coding region of prostaglandin G/H synthase from sheep vesicular glands. This cDNA, cloned from a lambda gt 10 library prepared from poly(A)+ RNA of vesicular glands, hybridizes with a single 2.75-kilobase mRNA species. The cDNA clone was selected using oligonucleotide probes modeled from amino acid sequences of tryptic peptides prepared from the purified enzyme. The full-length cDNA encodes a protein of 600 amino acids, including a signal sequence of 24 amino acids. Identification of the cDNA as coding for prostaglandin G/H synthase is based on comparison of amino acid sequences of seven peptides comprising 103 amino acids with the amino acid sequence deduced from the nucleotide sequence of the cDNA. The molecular weight of the unglycosylated enzyme lacking the signal peptide is 65,621. The synthase is a glycoprotein, and there are three potential sites for N-glycosylation, two of them in the amino-terminal half of the molecule. The serine reported to be acetylated by aspirin is at position 530, near the carboxyl terminus. There is no significant similarity between the sequence of the synthase and that of any other protein in amino acid or nucleotide sequence libraries, and a heme binding site(s) is not apparent from the amino acid sequence. The availability of a full-length cDNA clone coding for prostaglandin G/H synthase should facilitate studies of the regulation of expression of this enzyme and the structural features important for catalysis and for interaction with anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125548      PMCID: PMC279781          DOI: 10.1073/pnas.85.5.1412

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Two-dimensional thin-layer methods.

Authors:  R W Gracy
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

2.  Oxygenation of polyunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular gland.

Authors:  W L Smith; W E Lands
Journal:  Biochemistry       Date:  1972-08-15       Impact factor: 3.162

3.  Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes.

Authors:  S Ohki; N Ogino; S Yamamoto; O Hayaishi
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

4.  Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme.

Authors:  M Hemler; W E Lands
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

5.  Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase.

Authors:  G J Roth; E T Machuga; J Ozols
Journal:  Biochemistry       Date:  1983-09-27       Impact factor: 3.162

6.  Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands.

Authors:  F J Van der Ouderaa; M Buytenhek; D H Nugteren; D A Van Dorp
Journal:  Biochim Biophys Acta       Date:  1977-05-25

7.  Structural characteristics of prostaglandin synthetase from sheep vesicular gland.

Authors:  G J Roth; C J Siok; J Ozols
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase.

Authors:  T V Zenser; M B Mattammal; H J Armbrecht; B B Davis
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  71 in total

Review 1.  COX in a crystal ball: current status and future promise of prostaglandin research.

Authors:  G A FitzGerald; P Loll
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse.

Authors:  V Puigneró; J Queralt
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

Review 3.  The COXes of Danio: from mechanistic model to experimental therapeutics.

Authors:  Stephen M Prescott; H Joseph Yost
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

4.  Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.

Authors:  W N Charman; S A Charman; D C Monkhouse; S E Frisbee; E A Lockhart; S Weisman; G A Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

Review 5.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

Review 6.  Vasoconstrictor prostanoids.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-24       Impact factor: 3.657

Review 7.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

8.  PIOX, a new pathogen-induced oxygenase with homology to animal cyclooxygenase.

Authors:  A Sanz; J I Moreno; C Castresana
Journal:  Plant Cell       Date:  1998-09       Impact factor: 11.277

9.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.

Authors:  M Nakayama; K Uchimura; R L Zhu; T Nagayama; M E Rose; R A Stetler; P C Isakson; J Chen; S H Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 10.  Gene therapy for vascular diseases.

Authors:  K K Wu; P Zoldhelyi; J T Willerson; X M Xu; D S Loose-Mitchell; L H Wang
Journal:  Tex Heart Inst J       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.